Home/AEON Biopharma/Shelley Thunen
ST

Shelley Thunen

Board Member

AEON Biopharma

Therapeutic Areas

AEON Biopharma Pipeline

DrugIndicationPhase
ABP-450Episodic MigrainePhase 2